A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors

2014 ◽  
Vol 73 (3) ◽  
pp. 595-604 ◽  
Author(s):  
E. Gabriela Chiorean ◽  
Christopher Sweeney ◽  
Hagop Youssoufian ◽  
Amy Qin ◽  
Aruna Dontabhaktuni ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Growth Factor ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Growth Factor Receptor ◽  
Platelet Derived Growth Factor ◽  
Advanced Solid Tumors ◽  
Receptor Alpha ◽  
Factor Receptor Alpha

scholarly journals First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors

2020 ◽  
Vol 111 (2) ◽  
pp. 571-579 ◽  
Author(s):  
Takafumi Koyama ◽  
Toshio Shimizu ◽  
Satoru Iwasa ◽  
Yutaka Fujiwara ◽  
Shunsuke Kondo ◽  
...  
Keyword(s):  
Growth Factor ◽  
Phase I ◽  
Fibroblast Growth Factor ◽  
Solid Tumors ◽  
Phase I Study ◽  
Fibroblast Growth Factor Receptor ◽  
Growth Factor Receptor ◽  
Advanced Solid Tumors ◽  
Fibroblast Growth ◽  
Receptor Inhibitor
Sign in / Sign up

Export Citation Format

Share Document